My watch list  

Glioblastoma Multiforme

News Glioblastoma Multiforme

  • Heptares enters a Research and Drug Discovery Collaboration with New York University

    Heptares Therapeutics announces the launch of a new research collaboration under its ORBIT initiative with New York University (NYU) School of Medicine. This new collaboration will support a multi-year programme with NYU’s drug discovery accelerator group, the Office of Therapeutics Alliances (OTA) more

  • First use of graphene to detect cancer cells

    By interfacing brain cells onto graphene, researchers at the University of Illinois at Chicago have shown they can differentiate a single hyperactive cancerous cell from a normal cell, pointing the way to developing a simple, noninvasive tool for early cancer diagnosis. "This graphene system is able more

  • Novogen acquires privately-held neuro-oncology company

    Australian oncology-focused biotechnology company, Novogen Ltd announced that it has fully-acquired Glioblast Pty Ltd, a privately-held, neuro-oncology-focused Australian biotechnology company. The transaction includes an upfront payment of AU$ 2.1 million, comprising AU$ 600,000 in cash and ordinar more

All news on glioblastoma multiforme

Publications Glioblastoma Multiforme

All publications on glioblastoma multiforme
Related topics

Glioblastoma multiforme

Glioblastoma multiforme with contrast of a glioblastoma WHO grade IV in a 15-year-old boy with contrast of a glioblastoma WHO grade IV in a 15-year-old boy Glioblastoma multiforme (GBM), also known as grade 4 astrocytoma , is the most comm ... more


This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE